The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hormone Replacement Therapy (HRT) Market Research Report 2025

Global Hormone Replacement Therapy (HRT) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1886451

No of Pages : 99

Ask Your Query

Synopsis

Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.

The global Hormone Replacement Therapy (HRT) market was valued at US$ 16450 million in 2023 and is anticipated to reach US$ 20930 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo Nordisk, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 players combined 45.14% market share in all.

This report aims to provide a comprehensive presentation of the global market for Hormone Replacement Therapy (HRT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormone Replacement Therapy (HRT).

Report Scope

The Hormone Replacement Therapy (HRT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormone Replacement Therapy (HRT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hormone Replacement Therapy (HRT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Eli Lilly
  • Pfizer
  • AbbVie
  • Novo Nordisk
  • Merck
  • Mylan
  • Bayer
  • Teva
  • Novartis
  • Abbott
  • Roche
  • Endo International
  • Ipsen
  • ANI Pharmaceuticals
  • TherapeuticsMD

Segment by Type

  • Estrogen Hormone
  • Growth Hormone
  • Thyroid Hormone
  • Testosterone Hormone

Segment by Application

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Male Hypogonadism
  • Other Diseases

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hormone Replacement Therapy (HRT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hormone Replacement Therapy (HRT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Estrogen Hormone
1.2.3 Growth Hormone
1.2.4 Thyroid Hormone
1.2.5 Testosterone Hormone
1.3 Market by Application
1.3.1 Global Hormone Replacement Therapy (HRT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Menopause
1.3.3 Hypothyroidism
1.3.4 Growth Hormone Deficiency
1.3.5 Male Hypogonadism
1.3.6 Other Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hormone Replacement Therapy (HRT) Market Perspective (2019-2030)
2.2 Hormone Replacement Therapy (HRT) Growth Trends by Region
2.2.1 Global Hormone Replacement Therapy (HRT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hormone Replacement Therapy (HRT) Historic Market Size by Region (2019-2024)
2.2.3 Hormone Replacement Therapy (HRT) Forecasted Market Size by Region (2025-2030)
2.3 Hormone Replacement Therapy (HRT) Market Dynamics
2.3.1 Hormone Replacement Therapy (HRT) Industry Trends
2.3.2 Hormone Replacement Therapy (HRT) Market Drivers
2.3.3 Hormone Replacement Therapy (HRT) Market Challenges
2.3.4 Hormone Replacement Therapy (HRT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hormone Replacement Therapy (HRT) Players by Revenue
3.1.1 Global Top Hormone Replacement Therapy (HRT) Players by Revenue (2019-2024)
3.1.2 Global Hormone Replacement Therapy (HRT) Revenue Market Share by Players (2019-2024)
3.2 Global Hormone Replacement Therapy (HRT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hormone Replacement Therapy (HRT) Revenue
3.4 Global Hormone Replacement Therapy (HRT) Market Concentration Ratio
3.4.1 Global Hormone Replacement Therapy (HRT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hormone Replacement Therapy (HRT) Revenue in 2023
3.5 Hormone Replacement Therapy (HRT) Key Players Head office and Area Served
3.6 Key Players Hormone Replacement Therapy (HRT) Product Solution and Service
3.7 Date of Enter into Hormone Replacement Therapy (HRT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hormone Replacement Therapy (HRT) Breakdown Data by Type
4.1 Global Hormone Replacement Therapy (HRT) Historic Market Size by Type (2019-2024)
4.2 Global Hormone Replacement Therapy (HRT) Forecasted Market Size by Type (2025-2030)
5 Hormone Replacement Therapy (HRT) Breakdown Data by Application
5.1 Global Hormone Replacement Therapy (HRT) Historic Market Size by Application (2019-2024)
5.2 Global Hormone Replacement Therapy (HRT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hormone Replacement Therapy (HRT) Market Size (2019-2030)
6.2 North America Hormone Replacement Therapy (HRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hormone Replacement Therapy (HRT) Market Size by Country (2019-2024)
6.4 North America Hormone Replacement Therapy (HRT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hormone Replacement Therapy (HRT) Market Size (2019-2030)
7.2 Europe Hormone Replacement Therapy (HRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hormone Replacement Therapy (HRT) Market Size by Country (2019-2024)
7.4 Europe Hormone Replacement Therapy (HRT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hormone Replacement Therapy (HRT) Market Size (2019-2030)
8.2 Asia-Pacific Hormone Replacement Therapy (HRT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hormone Replacement Therapy (HRT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Hormone Replacement Therapy (HRT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hormone Replacement Therapy (HRT) Market Size (2019-2030)
9.2 Latin America Hormone Replacement Therapy (HRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hormone Replacement Therapy (HRT) Market Size by Country (2019-2024)
9.4 Latin America Hormone Replacement Therapy (HRT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hormone Replacement Therapy (HRT) Market Size (2019-2030)
10.2 Middle East & Africa Hormone Replacement Therapy (HRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hormone Replacement Therapy (HRT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Hormone Replacement Therapy (HRT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Hormone Replacement Therapy (HRT) Introduction
11.1.4 Eli Lilly Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hormone Replacement Therapy (HRT) Introduction
11.2.4 Pfizer Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Hormone Replacement Therapy (HRT) Introduction
11.3.4 AbbVie Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Hormone Replacement Therapy (HRT) Introduction
11.4.4 Novo Nordisk Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.4.5 Novo Nordisk Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Hormone Replacement Therapy (HRT) Introduction
11.5.4 Merck Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Hormone Replacement Therapy (HRT) Introduction
11.6.4 Mylan Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.6.5 Mylan Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Hormone Replacement Therapy (HRT) Introduction
11.7.4 Bayer Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Hormone Replacement Therapy (HRT) Introduction
11.8.4 Teva Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Hormone Replacement Therapy (HRT) Introduction
11.9.4 Novartis Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Hormone Replacement Therapy (HRT) Introduction
11.10.4 Abbott Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Hormone Replacement Therapy (HRT) Introduction
11.11.4 Roche Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Hormone Replacement Therapy (HRT) Introduction
11.12.4 Endo International Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Detail
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Hormone Replacement Therapy (HRT) Introduction
11.13.4 Ipsen Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Detail
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Hormone Replacement Therapy (HRT) Introduction
11.14.4 ANI Pharmaceuticals Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Detail
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Hormone Replacement Therapy (HRT) Introduction
11.15.4 TherapeuticsMD Revenue in Hormone Replacement Therapy (HRT) Business (2019-2024)
11.15.5 TherapeuticsMD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock